Gabapentin Tablet
Product Images NDC 80425-0035
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Gaba Figure 2
Gaba Figure 3
Gaba Figure 4
Gaba Table 6
This appears to be a table with information on a study that evaluates the efficacy of the drug Gabapentin in patients. The table shows the duration of two separate studies (8 weeks and 7 weeks) and the target doses of Gabapentin (3600 mg/day and 1800-2400 mg/day) for each study. The table also indicates the number of patients receiving Gabapentin and the number receiving a placebo for each study. However, without additional context or information, it is difficult to provide more details on the study or its findings.*
Gabapentin 800mg Tab Qty 30 Ndc 80425 0035
Gabapentin
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.